Literature DB >> 28860348

Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections.

Salvatore Piano1, Michele Bartoletti2, Marta Tonon1, Maurizio Baldassarre3, Giada Chies1, Antonietta Romano1, Pierluigi Viale2, Elia Vettore1, Marco Domenicali3, Marialuisa Stanco1, Chiara Pilutti1, Anna Chiara Frigo4, Alessandra Brocca1, Mauro Bernardi3, Paolo Caraceni3, Paolo Angeli1.   

Abstract

INTRODUCTION: Patients with cirrhosis have a high risk of sepsis, which confers a poor prognosis. The systemic inflammatory response syndrome (SIRS) criteria have several limitations in cirrhosis. Recently, new criteria for sepsis (Sepsis-3) have been suggested in the general population (increase of Sequential Organ Failure Assessment (SOFA) ≥2 points from baseline). Outside the intensive care unit (ICU), the quick SOFA (qSOFA (at least two among alteration in mental status, systolic blood pressure ≤100 mm Hg or respiratory rate ≥22/min)) was suggested to screen for sepsis. These criteria have never been evaluated in patients with cirrhosis. The aim of the study was to assess the ability of Sepsis-3 criteria in predicting in-hospital mortality in patients with cirrhosis and bacterial/fungal infections.
METHODS: 259 consecutive patients with cirrhosis and bacterial/fungal infections were prospectively included. Demographic, laboratory and microbiological data were collected at diagnosis of infection. Baseline SOFA was assessed using preadmission data. Patients were followed up until death, liver transplantation or discharge. Findings were externally validated (197 patients).
RESULTS: Sepsis-3 and qSOFA had significantly greater discrimination for in-hospital mortality (area under the receiver operating characteristic (AUROC)=0.784 and 0.732, respectively) than SIRS (AUROC=0.606) (p<0.01 for both). Similar results were observed in the validation cohort. Sepsis-3 (subdistribution HR (sHR)=5.47; p=0.006), qSOFA (sHR=1.99; p=0.020), Chronic Liver Failure Consortium Acute Decompensation score (sHR=1.05; p=0.001) and C reactive protein (sHR=1.01;p=0.034) were found to be independent predictors of in-hospital mortality. Patients with Sepsis-3 had higher incidence of acute-on-chronic liver failure, septic shock and transfer to ICU than those without Sepsis-3.
CONCLUSIONS: Sepsis-3 criteria are more accurate than SIRS criteria in predicting the severity of infections in patients with cirrhosis. qSOFA is a useful bedside tool to assess risk for worse outcomes in these patients. Patients with Sepsis-3 and positive qSOFA deserve more intensive management and strict surveillance. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute on chronic liver failure; liver cirrhosis; liver transplantation; sepsis; septic shock

Mesh:

Year:  2017        PMID: 28860348     DOI: 10.1136/gutjnl-2017-314324

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Bacterial infections in cirrhotic patients.

Authors:  Bilge Örmeci Baş; Ayhan Hilmi Çekin
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

2.  Prognostic accuracy of the sequential organ failure assessment (SOFA) and quick SOFA for mortality in cancer patients with sepsis defined by systemic inflammatory response syndrome (SIRS).

Authors:  Bo-Ra Chae; Youn-Jung Kim; Yoon-Seon Lee
Journal:  Support Care Cancer       Date:  2019-05-22       Impact factor: 3.603

3.  qSOFA score not predictive of in-hospital mortality in emergency patients with decompensated liver cirrhosis.

Authors:  M Müller; J C Schefold; A B Leichtle; D Srivastava; G Lindner; A K Exadaktylos; C A Pfortmueller
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-08-21       Impact factor: 0.840

Review 4.  Current Concepts on Bacterial and Fungal Infections in Cirrhosis.

Authors:  Salvatore Piano; Paolo Angeli
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

5.  Relationship Between Etiology of Cirrhosis and Survival Among Patients Hospitalized in Intensive Care Units.

Authors:  Chansong Choi; Dae Hee Choi; Grant M Spears; Thoetchai Bee Peeraphatdit; Laura Piccolo Serafim; Ognjen Gajic; Patrick S Kamath; Vijay H Shah; Alice Gallo de Moraes; Douglas A Simonetto
Journal:  Mayo Clin Proc       Date:  2022-01-25       Impact factor: 7.616

Review 6.  Overview of Complications in Cirrhosis.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-05-14

7.  ACG Clinical Guideline: Alcoholic Liver Disease.

Authors:  Ashwani K Singal; Ramon Bataller; Joseph Ahn; Patrick S Kamath; Vijay H Shah
Journal:  Am J Gastroenterol       Date:  2018-01-16       Impact factor: 10.864

Review 8.  Intensive Care Therapy for Patients with Advanced Liver Diseases.

Authors:  Antonios Katsounas; Ali Canbay
Journal:  Visc Med       Date:  2018-08-08

Review 9.  Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure.

Authors:  Cornelius Engelmann; Thomas Berg
Journal:  Visc Med       Date:  2018-07-27

10.  Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018.

Authors:  Paolo Gaibani; Donatella Lombardo; Linda Bussini; Federica Bovo; Beatrice Munari; Maddalena Giannella; Michele Bartoletti; Pierluigi Viale; Tiziana Lazzarotto; Simone Ambretti
Journal:  Antibiotics (Basel)       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.